Platelet Aggregation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

The global platelet aggregation devices market was valued at USD 365.54 million in 2023, growing at a CAGR of 7.85% during the forecast period from 2024 to 2030 to reach USD 573.25 million by 2030. The platelet aggregation devices market is witnessing positive growth owing to various factors such as the rising prevalence of cardiovascular, hematological, and other target disorders and surging burden of geriatric population across the globe. Further, technological advancements in platelet aggregometers, for instance accurate and automatic testing of platelets and other advancements will increase the demand of the device in the forthcoming years. Additionally, the rise in the number of industry-academia collaborations and clinical studies in the healthcare industry will also contribute in the growth of platelet aggregation devices market. Also, the increasing regulatory approvals and launches across the globe will further increase the overall growth of the platelet aggregation devices market. Therefore, the market for platelet aggregation devices market is estimated to grow at a significant CAGR during the forecast period from 2024 to 2030.

Platelet Aggregation Devices Market Dynamics:

One of the main driver for the platelet aggregation devices market is the increasing figures of bleeding and haematological disorders.

For instance, the National Organization for Rare Disorders (NORD) stated in a latest study the incidence of adult Immune thrombocytopenia (ITP) in the United States was roughly estimated to be 3.3 per 100,000/year. Also, the prevalence od ITP was reported to be 9.5 per 100,000. Further, in a study done by the Maryland Health Care Commission (2023), the prevalence of ITP was estimated to be 9.5 per 100,000 children ages 1-5, 7.3 per 100,000 in children ages 6-10, and 4.1 per 100,000 in children of ages 11-14, in 2022, in the United States.

Immune thrombocytopenia (ITP) is a type of platelet disorder, whose diagnosis can be done with the help of platelet aggregation devices market. Thus, the increasing figures of ITP will increase the number of diagnosis test, ultimately rising the demand of the platelet aggregation devices market.

Further, increasing incidence of other bleeding and platelet disorder will drive the market of platelet aggregation devices market. For instance, Bernard-Soulier syndrome is a rare bleeding disorder that affects males and females in equal numbers. Recent study done by NORD suggests that Bernard Soulier syndrome affects 1 in a million people. More than 200 cases have been reported in 2022, worldwide. The detection of such syndromes can be done using platelet aggregation devices market.

Additionally, the demand for platelet aggregation systems is increasing in academic and pharmaceutical companies due to the increase in research studies, mainly to know the mechanisms involved in the interaction of platelets with vascular surfaces and evaluation and screening anti-thrombotic factors to know new targets for antiplatelet drugs. Thus, the increasing research & developmental activities and clinical trials will propel the demand of the device in the market in upcoming years.

Therefore, the factors stated above collectively will drive the overall market of platelet aggregation devices market during the forecast period from 2024-2030.

However, reduced product availability, lack of trained and skilled professionals, procedural limitations, and others, can hinder the global platelet aggregation devices market growth.

The COVID-19 pandemic has negatively impacted the market for platelet aggregation devices market. The outbreak of the pandemic led to the cancellation of outpatient visits and the suspension of non-emergency hospitals and surgical procedures for chronic disorders such as cancers, diabetes, cardiovascular disorders, and others. Moreover, the number of diagnostic tests many disorders were reduced as the priority was given to the COVID-19 testing. Further, due to imposition of strict lockdown rules the manufacturing of the devices was ceased. However, vaccine development of COVID-19 has produced the process of economic recovery with the easing of lockdown restrictions and the return of normalcy in the economic landscape which has initiated the process of resumption of regular healthcare services, diagnostic tests, and surgical procedures for the treatment and management of various diseases ultimately increasing the demand of platelet aggregation devices market, thereby bringing the demand for device on track in the platelet aggregation devices market.

Platelet Aggregation Devices Market Segment Analysis:

Platelet aggregation devices market by Product Type (Systems, Reagents, and Consumables & Accessories), Application (Clinical Applications and Research Applications), End-User (Hospitals, Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the platelet aggregation devices market, the systems market is expected to have a significant revenue share in the year 2023. This was primarily owing to the application of the segment. Moreover, the advantages such as accuracy, portability, and others offered by the systems along with the increasing product launches in the market will spur the demand of the segment in the upcoming years.

The systems are specifically designed to support diagnoses of hemostasis disorders including von Willebrand Disease (vWD), Glanzmann’s disease, HIT, Bernard Soulier Syndrome, Sticky Platelet Syndrome, and others. The platelet aggregation systems can also be used to precisely monitor the use of anti-platelet drugs during clinical trials or patient therapy. Moreover, the system measures the rate and extent of aggregation, agglutination, activation and inhibition reactions. Thus, the increasing prevalence of any of the above disorder can propel the demand of systems segment in the forecast period.

Further, the automated platelet aggregometry systems offer various advantages such as accuracy, reduced platelet-rich plasma volume and time, simultaneous assay and test conduction, and other advantages will increase its demand in the market.

The rising regulatory activities and launches will in turn propel the demand of the systems in the market, thereby propelling the overall growth of platelet aggregation devices market. For instance, in March 2020, Hart Bio launched ADP MEA and TRAP-6 MEA, designed to monitor and test the platelet aggregation function of patients. Both ADP MEA and TRAP-6 MEA are designed to monitor and test the platelet aggregation function of patients.

Thus, the above-mentioned factors will in turn drive the systems segment market in platelet aggregation devices market, thereby propelling the overall market growth of platelet aggregation devices market in the forecast period from 2022 - 2028.

North America is expected to dominate the overall Platelet Aggregation Devices Market:

Among all the regions, North America is expected to dominate the global platelet aggregation devices market in the year 2023 and is expected to do the same during the forecast period from 2024-2030. Factors such as the increasing number of target disorders, increasing geriatric population, technological advancements in platelet aggregometer, rising awareness among healthcare professionals regarding the benefits offered by platelet aggregation testing in disease diagnosis, and others will increase the demand for platelet aggregation devices market in North America, leading to a rise in the overall platelet aggregation devices market growth.

For instance, as per a report provided by Centers for Disease Control (CDC) in 2022, every 40 seconds, an American may have a heart attack. Platelet function tests using platelet aggregation devices market are used to monitor the antiplatelet drugs as a means to predict in cardiovascular disease. Thus, increasing prevalence of cardiovascular disorders in the North America will increase the number of platelet function test, thus leading to a higher demand for platelet aggregation devices market, which will drive the market in the North America.

Further, the increasing prevalence of bleeding and hematological disorders will shoot the demand of the device. According to the World Federation of Hemophilia 2022 report, there were about 14,816 patients with hemophilia including (Hemophilia A -11,790 and Hemophilia B-3,026) in the United States in 2020 and 3,924 patients with hemophilia in Canada in 2020 including (Hemophilia A -3,223 and Hemophilia B-701). Therefore, platelet aggregation testing is found to be very beneficial in disease diagnosis.

Additionally, factors such as the rising number of surgical procedures in this country, a large number of the population undergoing cardiovascular surgeries, increasing prevalence of orthopedic, bleeding, and urological disorders are creating high growth opportunities for the market players in the North America.

Therefore, the interplay of the aforementioned factors above would provide a conducive growth environment for the North American region in the platelet aggregation devices market.

Platelet Aggregation Devices Market Key Players:

Some of the key market players operating in the platelet aggregation devices market include F. Hoffmann-La Roche Ltd, Werfen, Drucker Diagnostics, Haemonetics Corporation, Sienco, Inc., BIO/DATA CORPORATION, AggreDYNE, Siemens Healthcare Private Limited, Chrono-log Corporation, Grifols, S.A., Helena Laboratories Corporation., SENTINEL., Sysmex Corporation, Matis Medical Inc., Elektronik GmbH & Co., and others.

Recent Developmental Activities in the Platelet Aggregation Devices Market:

• In July 2022, Sysmex Corporation, a leading name in the global platelet aggregation devices marketplace, announced the launch of new automated blood coagulation analyzers. CN-3500 and CN-6500 are capable of measuring platelet aggregation parameters and blood coagulation in hemostasis and thrombosis fields.
• In December 2020, Basking Biosciences Inc., a private biopharmaceutical organization, announced that it had successfully raised US$ 5.4 million in a seed financing round. The company was working on exploring the role of vWF, a redundant mediator of platelet adhesion and aggregation, to develop a reversible thrombolytic therapy for acute ischemic stroke. Rising outbreaks of dengue & malaria and growing incidence of blood cancer are also expected to drive platelet aggregation system demand in this region.
• In April 2019, Aggredyne Inc. received the US FDA approval for AggreGuide A-100 ADP assay testing cartridge, an in vitro diagnostic device used for measuring various antiplatelet medications that target the platelet P2Y12 receptor.

Key Takeaways from the Platelet Aggregation Devices Market Report Study

• Market size analysis for current platelet aggregation devices market (2023), and market forecast for 6 years (2024-2030)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the platelet aggregation devices market
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
• Key companies dominating the global platelet aggregation devices market
• Various opportunities are available for the other competitor in the platelet aggregation devices market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030.
• Which are the top-performing regions and countries in the current platelet aggregation devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for platelet aggregation devices market growth in the coming future?

Target Audience who can be benefited from this Platelet Aggregation Devices Market Report Study

• Platelet aggregation devices market providers
• Research organizations and consulting companies
• Platelet aggregation devices market -related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in platelet aggregation devices market
• Various end-users who want to know more about the platelet aggregation devices market and the latest technological developments in the platelet aggregation devices market

Frequently Asked Questions for Platelet Aggregation Devices Market:

1. What are platelet aggregation devices market?

Platelet aggregation is the procedure in which the platelets are clomped together in the blood which leads to the formation of a thrombus or clot. The devices involved in the aggregation of platelets are termed as platelet aggregation devices market. The aggrometers, one of the medical device used in platelet aggregation, works against the clotting, to further stop the clot formation. This process is used for the diagnosis and identification of the defects in platelet functions.

2. What is the market for Platelet aggregation devices market?

The global platelet aggregation devices market was valued at USD 365.54 million in 2023, growing at a CAGR of 7.85% during the forecast period from 2024 to 2030 to reach USD 573.25 million by 2030.

3. What are the drivers for the platelet aggregation devices market?

The platelet aggregation devices market is observing an affirmative market growth owing to the factors such as rising prevalence of cardiovascular, haematological, and other target disorders, surging burden of geriatric population, technological advancements in platelet aggregometers, rise in the number of industry-academia collaborations and clinical studies, and the upsurge in the regulatory approvals for platelet aggregation devices market.

4. Who are the key players operating in the platelet aggregation devices market?

Some of the key market players operating in the platelet aggregation devices market include F. Hoffmann-La Roche Ltd, Werfen, Drucker Diagnostics, Haemonetics Corporation, Sienco, Inc., BIO/DATA CORPORATION, AggreDYNE, Siemens Healthcare Private Limited, Chrono-log Corporation, Grifols, S.A., Helena Laboratories Corporation., SENTINEL., Sysmex Corporation, Matis Medical Inc., Elektronik GmbH & Co., and others.

5. Which region has the highest share in platelet aggregation devices market?

North America is expected to dominate the global platelet aggregation devices market. Factors contributing to the growth are the rising number of cardiovascular surgeries, rising number of orthopaedic, urological, bleeding, and disorders, escalating burden of geriatric patients, and others which are contributing to the growth of the platelet aggregation devices market in the North America region.


This product will be delivered within 2 business days.